FDA's label warnings go to doctors overwhelmed by promotional material

04/14/2005 | Bloomberg Businessweek

The FDA may require strong warnings on labels similar to that ordered on Celebrex last week, but that does not mean prescribing physicians, let alone their patients, will see or heed them. The warnings to physicians generally come in the form of letters that are overlooked and the doctors often are overwhelmed by promotional material given out by drug company representatives sent to visit physician offices.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX